Year: 2026

GIGABYTE Demonstrates AI TOP ATOM Four-Node Clustering on Scientific Computing

TAIPEI, July 7, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…

New7Wonders Honours the Official 7 Wonders Day this year in Viet Nam

ZURICH, July 7, 2026 /PRNewswire/ -- New7Wonders is proud to announce that 7…

SAUDI INTRODUCES “PACKAGE VISA”, INTEGRATING TRAVEL BOOKING WITH EASIER VISA APPLICATION

A fully digital initiative connecting visa application directly to travel bookings, making…

Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma

EAST RUTHERFORD, N.J., July 7, 2026 /PRNewswire/ -- Cambrex, a leading global contract…

PRNW Agency

Prayogtvisha Launches STEM Education Programme Pilot at SSV International School, Guntur

BENGALURU, India, July 7, 2026 /PRNewswire/ -- Prayogtvisha, an education company founded…

PRNW Agency

Giftex unveils The Collectors’ Cove: India’s only collector-first destination celebrating remarkable works, objects and exceptional craftsmanship

~An invitation-only cultural platform bringing together outstanding works, collectible objects and the…

PRNW Agency

Healome Therapeutics Closes 2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases

BIRMINGHAM, England, July 7, 2026 /PRNewswire/ -- Healome Therapeutics ("Healome"), a University…

Medicine Beyond Borders: Zydus Hospital, Ahmedabad, Emerges as a Preferred Destination for International Patients

AHMEDABAD, India, July 7, 2026 /PRNewswire/ -- Quality healthcare should never be a…

Presentation of New Clinical Data on Givinostat in Duchenne Muscular Dystrophy at ICNMD 2026

Phase 3 EPIDYS MRI data quantify givinostat’s potential to preserve functional muscle…

GlobeNews Wire

ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs

Investigational n.c.a. 177Lu-edotreotide (ITM-11) demonstrated a significantly higher progression-free survival and objective…

GlobeNews Wire